Specious "Backorder" Claims: My New Realizations (and Timeless Advice)
Hey folks – I hope everyone is enjoying the advent of the spring season as well as the recent resolution of the shortage that began all the way back on 3/17/23.
Thankfully, the loud clamor (the kind we saw start up in late 2022) has long since yielded to the usual topics of efficacy, ADHD, and first-time fills –– expected, since Desoxyn has not been this available since late 2022.
Despite this indisputable reality, reports of persistent issues continue to crop up sporadically, often relaying specious "backorder" claims made by pharmacists. I do actually believe those pharmacists – in part. Here's what I think is happening: "I can't order it, so supply must be low*"* is a near-airtight assumption in every normal scenario*....*
...But it's still an assumption. His definitive knowledge (i.e., he couldn't order it from his warehouse at that moment) is much thinner. And, as it turns out, Desoxyn's rarity makes it the antithesis of a normal scenario. The truth? The pharmacist may just be seeing an artefact of low demand. Perhaps for the first time in his career! It's very conceivable that an empty local warehouse is just a reflection of there being literally not a single Desoxyn patient in your vicinity other than yourself. Remember, your pharmacist can't order from other warehouses, and he definitely can't place a purchase order with Ajenat or Hikma.
BUT! If you patiently keep the prescription active, the system should flag the unmet demand. The flag should get processed higher up the chain behind the scenes, allocating stock to the empty warehouse and prompting your pharmacy to order and fill it (and to boot, a lot quicker than you think). Perhaps people have reported failure with this method, but I can't think of one single such instance.
***Disclaimer: While I think my reasoning is sound, I have zero insider knowledge or firsthand experience with retail pharmacy distribution systems, so take my words with a grain of salt. At the end of the day, the method's efficacy is the only thing of tangible importance.
***Off-topic but perhaps worth mentioning: My refill from a few days ago says "Dr. Reddy's" in lieu of "Mayne" for the first time. Since it's the still the same contract factory producing the same formulation, perhaps the variable here is a fresh batch. No more soft, dusty tablets – these are very hard (breaking one out of curiosity left a lil dent in my finger!). I'm not one to notice variation in batch efficacy, but these do seem to be a fresh, higher-integrity product.